Pharma West Africa 2026 Concludes, Boosting Nigeria's Healthcare Investment Appeal
The third edition of Pharma West Africa concluded at the Landmark Event Centre in Lagos, running from April 14 to 16, 2026. This event has significantly heightened the focus of global pharmaceutical investors on Nigeria and the broader West African sub-region, reinforcing the country's strategic position in the healthcare sector.
Record-Breaking Exhibition and Growing Interest
Organised by Trade Show Organisers, the three-day exhibition attracted over 250 exhibitors and participants from Europe, Asia, and Africa. Exhibition Manager Kieran Westlake described it as one of the fastest-growing trade shows in the region, driven by increasing global interest in Nigeria's pharmaceutical market. "I remember launching this show two years ago, and it has become one of the fastest-growing exhibitions we've done as a business," Westlake said. "We've got record-breaking exhibitors now from all over the globe, including country pavilions from Turkey, China, Egypt, Bangladesh, and St. Petersburg. It's growing bigger and bigger." He added that the 2026 edition saw unprecedented visitor registrations, reflecting its rising importance in connecting investors with local opportunities.
International and Regional Participation
Findings at the exhibition revealed strong participation from international and regional companies, many expressing readiness to expand into the Nigerian market through strategic partnerships. A representative from the Turkish pharmaceutical firm Abdi İbrahim stated, "We see Nigeria as a strategic market in Africa. The population, demand for healthcare products, and the openness to partnerships make it very attractive for us." Similarly, a delegate from Geropharm LLC in Russia noted that the exhibition provided a direct pathway to engage with local distributors and regulators, calling it a critical step for market entry.
Focus on Regional Integration and Collaboration
Suresh Gondalia, Chairman of True Drug Pharma Private Limited in India, highlighted the importance of regional integration in driving growth. "We are not just looking at Nigeria alone, but the entire West African market. Events like this help us build the networks needed to scale across the region," he stated. Westlake emphasised that the exhibition was intentionally designed as a regional platform, bringing together pharmacists, government officials, and business leaders to foster collaboration. "We didn't want to pigeonhole the event to one country. We want to build the biggest pharmaceutical exhibition in West Africa, and that's why we have a strong conference featuring industry leaders and international experts," he explained.
Growth and Partnerships
Westlake traced the exhibition's evolution from a modest inaugural edition dominated by local firms to a global event with diverse participation. "In the first year, about 70 per cent of exhibitors were local, and we had just one hall. Now, in the third edition, we have over 250 exhibitors and six country pavilions. The opportunities are much bigger for both international and local players," he added. He noted that partnerships between foreign companies and Nigerian firms had become a defining feature, with many companies exhibiting alongside their regional partners, underscoring the necessity of local collaboration for effective operations.
Policy Changes and Future Outlook
On recent policy changes, including the Federal Government's reduction in import duties on pharmaceutical products, stakeholders expressed optimism that this would boost access and investment. Westlake commented, "International companies understand the regulatory process, but policies like this will certainly make the market more attractive and accessible." Industry observers noted that Nigeria's large population, growing healthcare needs, and evolving policy environment continue to position the country as a major pharmaceutical hub in Africa. They added that Pharma West Africa has become a critical meeting point for investors and local stakeholders, driving partnerships, knowledge exchange, and long-term investments in the sector.
